|
Volumn 7, Issue 6, 2001, Pages 1505-1510
|
Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with 111Indium, 67Gallium, or 90Yttrium
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY CD74 GA 67;
MONOCLONAL ANTIBODY CD74 IN 111;
MONOCLONAL ANTIBODY CD74 Y 90;
MONOCLONAL ANTIBODY MN 14;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
B CELL LYMPHOMA;
CANCER IMMUNOTHERAPY;
CONTROLLED STUDY;
DRUG CONJUGATION;
FEMALE;
HUMAN;
HUMAN CELL;
IMMUNOSTIMULATION;
ISOTOPE LABELING;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
RADIOIMMUNOTHERAPY;
SCID MOUSE;
TUMOR XENOGRAFT;
ANIMALS;
ANTIBODIES;
ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE;
FEMALE;
GALLIUM RADIOISOTOPES;
HISTOCOMPATIBILITY ANTIGENS CLASS II;
HUMANS;
INDIUM RADIOISOTOPES;
LYMPHOMA, B-CELL;
MAXIMUM TOLERATED DOSE;
MICE;
MICE, SCID;
NEOPLASM TRANSPLANTATION;
PROTEIN BINDING;
TIME FACTORS;
TUMOR CELLS, CULTURED;
YTTRIUM RADIOISOTOPES;
|
EID: 0034895515
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (50)
|
References (32)
|